AMERICAN VANGUARD CORP — fact timeline

AMERICAN VANGUARD CORP incurred term loan of $60 million with BMO Bank N.A. at SOFR-based rate plus an applicable margin of 2.00% per annum, subject to a SOFR maturing March 13, 2031.

“of the Company, including AMVAC. Second Lien Term Loan The Second Lien Term Loan is a secured term loan facility with a five year term for an aggregate principal amount of $60 million. The Second Lien Term Loan contains customary representations and warranties, affirmative and negative covenants and events of default for financings of this type. AMVAC is”

AMERICAN VANGUARD CORP incurred term loan of $225 million with Centerbridge Partners, L.P. at SOFR-based rate plus an applicable margin initially equal to 8.25% per annum maturing March 13, 2031.

“permitted under the Term Loans. First Lien Term Loan The First Lien Term Loan is a senior secured term loan facility with a five year term for an aggregate principal amount of $225 million. The First Lien Term Loan contains customary representations and warranties, affirmative and negative covenants and events of default for financings of this type. AMVAC is”

AMERICAN VANGUARD CORP terminated Third Amended and Restated Credit Agreement with Not specified valued at Termination of Prior Credit Agreement, retirement of all outstanding loans using proceeds from Term (effective 2026-03-13).

“On March 13, 2026, AMVAC, as borrower, and certain affiliates (including the Company), as guarantors and/or borrowers, terminated the Prior Credit Agreement concurrently with its entry into the Term Loans (as more fully described in Item 1.01, which is incorporated by reference herein)”

AMERICAN VANGUARD CORP entered into Credit and Guaranty Agreement (First Lien Term Loan) with Centerbridge Partners, L.P. and Wilmington Trust, National Association valued at $225 million senior secured term loan facility (effective 2026-03-13).

“On March 13, 2026, AMVAC Chemical Corporation (“AMVAC”), a subsidiary of American Vanguard Corporation (the “Company”), as borrower, and certain affiliates of the Company (including the Company), as guarantors, entered into (i) a Credit and Guaranty Agreement (the “First Lien Term Loan”) with a group of commercial lenders led by Centerbridge Partners, L.P., and Wilmington Trust, National Association as administrative agent”

AMERICAN VANGUARD CORP amended revolving credit of $245,000,000 with BMO Bank, N.A. maturing December 31, 2026.

“On August 18, 2025, AMVAC Chemical Corporation (“AMVAC”), principal operating subsidiary of American Vanguard Corporation (“Registrant” or the “Company”), as borrower, and affiliates (including Registrant), as guarantors and/or borrowers, entered into Amendment Number Twelve (the “Amendment”) to the Third Amended and Restated Loan and Security Agreement (the “Loan Agreement”) with a group of commercial lenders led by BMO Bank, N.A. (successor to the Bank of the West), as administrative agent for the lenders. The Amendment extends the maturity date of the Loan Agreement from August 5, 2026 to December 31, 2026 (the “Loan Extension”) and amends the borrowing capacity under the revolving credit facility to $245,000,000 through November 29, 2025, then $225,000,000 until December 30, 2025, then $200,000,000 until March 31, 2026 and then $180,000,000 through December 31, 2026.”

AMERICAN VANGUARD CORP received a nyse noncompliance notice notice regarding late filing (rules 802.01E).

“June 6, 2025, the Company received written notice from NYSE Regulation closing this matter and confirming that the Company had regained compliance with Section 802.01E of the NYSE Listed Company Manual. The notice followed the Company filing the Form 10-K and its Form 10-Q for the fiscal quarter ended March 31, 2025.”

Timothy Donnelly was appointed as Acting Chief Executive Officer at AMERICAN VANGUARD CORP.

“Mr. Donnelly has also been designated as, and assumed the duties of, the Company’s Acting Chief Executive Officer and acting principal executive officer as of July 12, 2024.”

Eric Wintemute changed role as Chief Executive Officer at AMERICAN VANGUARD CORP.

“Effective as of July 12, 2024, Eric Wintemute concluded his role as Chief Executive Officer of American Vanguard Corporation (the “Company”).”

Eric Wintemute retired as Chief Executive Officer at AMERICAN VANGUARD CORP.

“Effective as of July 3, 2024, American Vanguard Corporation (the “Company” or “Registrant”) and Eric Wintemute, the Company’s Chairman and CEO, entered into a Transition Agreement, which set forth the terms and conditions of Mr. Wintemute’s retirement.”

AMERICAN VANGUARD CORP reported the first quarter ended March 31, 2024 results: revenue $135 million, net income $1.6 million, EPS $0.06. Guidance reaffirmed.

“(NYSE: AVD) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights – versus First Quarter 2023: • Net sales of $135 million vs. $125 million • Adjusted EBITDA 1 of $15.5 million vs. $11.5 million • Operating Income of $6.1 million vs. $3.3 million • Net income of $1.6 million vs. $1.9 million •”

AMERICAN VANGUARD CORP reported financial results for three- and twelve-month periods ended December 31, 2023.

“On March 14, 2024, American Vanguard Corporation (“Registrant”) issued a press release announcing financial results for the three- and twelve-month periods ended December 31, 2023.”

Steven Macicek was appointed as Director at AMERICAN VANGUARD CORP.

“Registrant announced its board of directors had appointed Steven Macicek to fill the vacancy to be created by Mr. Erlich’s departure and to commence service on its board effective after the close of business on day upon which Mr. Erlich’s retirement is deemed to be effective (which, in all probability) will be March 15, 2024.”

Morton D. Erlich retired as Director at AMERICAN VANGUARD CORP.

“On March 7, 2024, American Vanguard Corporation (“Registrant”) issued a press release announcing that Morton D. Erlich had retired from Registrant’s board of directors”